Article
In-vitro activity of Cefiderocol against clinical isolates of meropenem-resistant…
medRxiv · 2022 · Borde K, Kareem MA, Sharma RM, Dass SM, Ravi V, Mathai D.
Key facts
| Title | In-vitro activity of Cefiderocol against clinical isolates of meropenem-resistant <i>Klebsiella pneumoniae</i> from India |
|---|---|
| First author | Borde K, Kareem MA, Sharma RM, Dass SM, Ravi V, Mathai D. |
| Journal | medRxiv |
| Published | Sep 17, 2022 |
| DOI | 10.1101/2022.09.16.508352 |
| Devices mentioned | K212849, K230479 |
| Product codes mentioned | JWY, LON |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1